3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients
Leave reply:
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Follow Kairos Ventures on LinkedIn
Subscribe to Kairos News
Recent Posts
- A Breakthrough Heart Procedure Comes With Risky Tradeoffs
- 5 next-gen heart valve replacement companies you need to know
- Sivers collaborates with Jabil on energy-efficient 1.6T pluggable optical transceiver module
- Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Fast and Furious: Aerospace Firms Reduce Hypersonic Design to Months, Not Years